SNDL SNDL Inc. logo

SNDL SNDL Inc.

Healthcare
$1.45-1.36%ClosedMarket Cap: $375.8M

As of 2026-05-25

Valuation

View Details

P/E (TTM)

PEG

P/B

0.48

P/S

0.55

EV/EBITDA

9.14

DCF Value

$-60.23

FCF Yield

10.2%

Div Yield

0.0%

Margins & Returns

Gross Margin

27.2%

Operating Margin

-0.8%

Net Margin

-1.2%

ROE

-1.0%

ROA

-0.8%

ROIC

-0.5%

Financials

View All
PeriodRevenueNet IncomeEPS
Q1 null$195.9M$-9.9M$
Q4 null$252.5M$9.4M$
FY null$946.4M$-15.8M$
Q3 null$244.2M$-13.3M$

Analyst Ratings

View All

Consensus

Buy

Target (Consensus)

$3.95

Target (Median)

$3.60

Target Range

$3.25 - $5.00

1 Strong Buy1 Buy0 Hold0 Sell0 Strong Sell

Company Info

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Country

CA

Exchange

Beta

0.88

SNDL Inc. engages in the production, distribution, and sale of cannabis products in Canada. The company operates through Cannabis Operations and Retail Operations segments. It engages in the cultivation, distribution, and sale of cannabis for the adult-use markets; and private sale of recreational cannabis through corporate owned and franchised retail cannabis stores. The company also produces and distributes inhalable products, such as flower, pre-rolls, and vapes. It offers its products under the Top Leaf, Sundial Cannabis, Palmetto, and Grasslands brands. The company was formerly known as Sundial Growers Inc. and changed its name to SNDL Inc. in July 2022. SNDL Inc. was incorporated in 2006 and is headquartered in Calgary, Canada.

Peers